drugset

drugset / Trial / NCT00947076

To Demonstrate the Relative Bioavailability of Fluoxetine Hydrochloride Capsules, 40 mg

NCT00947076 ↗

Phase 1 Completed 30 enrolled Sandoz

RandomizedCrossoverOpen-labelTreatment

Summary

To demonstrate the relative bioavailability of fluoxetine hydrochloride capsules, 40 mg.

Timeline

Start: 2001-02
Primary completion: 2001-04
Completion: 2001-04

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Fluoxetine	Small molecule	40 mg	—

Indications